Clinical Trial Update: Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342 [Phase 2]

View source ↗

Summary

Phase 2 study assessing gene activation in healthy adults after vaccination with GSK's TB vaccine candidate GSK 692342; trial completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• GSK 692342

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2019-03-22